Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pleural Malignancy × Ultraviolet Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 6 Fatigue 6 Sezary Syndrome 3 Mycosis Fungoides 3 Lymphoma 3 Prostatic Neoplasms 2 Lymphoma, T-Cell, Cutaneous 2 Leukemia 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Sleep Wake Disorders 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Malignancy 1 Parasomnias 1 Neoplasms, Plasma Cell 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1

Interventions

Ultraviolet Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01673074 2020-04-08

HPPH and PDT for Pleural Malignancy

Abramson Cancer Center at Penn Medicine

Phase 1 Completed

Pleural Malignancy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡